About This Calculator

The Diltiazem Infusion Calculator is a clinical support tool designed for healthcare professionals to streamline the dosing and administration of intravenous diltiazem. It helps determine appropriate infusion rates and bolus doses for patients, primarily in the management of atrial fibrillation or flutter with rapid ventricular response (RVR).

This guide provides an overview of the calculator's functions, outputs, and the clinical context for its use. All calculations must be verified by a qualified professional before clinical application.

Outputs Explained

After you input the required patient and drug information, the calculator provides the following key outputs for the maintenance infusion and initial bolus:

  • Infusion Rate (mL/hr): The speed at which the infusion pump should be set to deliver the desired dose based on the specified diltiazem concentration.
  • Dose (Weight-Based, mcg/kg/min): A standardized, weight-based expression of the infusion dose, useful for clinical documentation and communication.
  • Dose (Time-Based, mg/hr): The total amount of diltiazem the patient receives per hour, which is the most common way to titrate the infusion.
  • Calculated Bolus (mg and mL): The total milligrams of diltiazem for the initial IV push dose and the corresponding volume to draw up, assuming a standard vial concentration of 5 mg/mL.

How to Use the Calculator

Follow these steps to accurately calculate diltiazem dosing:

  1. Enter Patient Weight: Input the patient's actual body weight and select the correct unit (kg or lbs).
  2. Set Diltiazem Concentration: Choose a standard premixed bag concentration (e.g., 125 mg / 100 mL) or select "Custom" to enter the total milligrams of diltiazem and total milliliters of fluid for a non-standard mixture.
  3. Select Calculation Mode:
    • Choose "Calculate Rate from Desired Dose" if you know the target dose (e.g., 10 mg/hr) and need to find the pump rate (mL/hr).
    • Choose "Calculate Dose from Current Rate" if the patient is already on an infusion at a known rate (e.g., 8 mL/hr) and you need to find the corresponding dose (mg/hr).
  4. Input the Known Value: Enter the desired dose or the current infusion rate into the active field.
  5. Review Results: The calculator will instantly display the calculated infusion rate and dose in all relevant units.
  6. Calculate Bolus Dose: The bolus calculator uses the patient's weight to determine the standard 0.25 mg/kg IV push dose. You can adjust the mg/kg value if a different dose is required.

Dosing Overview

Diltiazem dosing for rate control in atrial fibrillation typically follows a two-part process involving a bolus and a continuous infusion.

Initial IV Bolus

An initial loading dose is given to achieve a rapid therapeutic effect.

  • Standard Dose: 0.25 mg/kg of actual body weight, administered as an IV push over 2 minutes.
  • Repeat Bolus: If the initial response is inadequate after 15 minutes, a second bolus of 0.35 mg/kg may be given.

Maintenance Infusion

A continuous infusion is started to maintain heart rate control.

  • Starting Rate: Typically initiated at 5 to 10 mg/hr.
  • Titration: The rate can be increased in increments of 2.5 to 5 mg/hr every 15-30 minutes to achieve the target heart rate.
  • Maximum Rate: Generally, the infusion should not exceed 15 mg/hr, although doses up to 20 mg/hr may be used in specific situations with close monitoring.

Switching to Oral Therapy

Transitioning from an intravenous diltiazem infusion to an oral formulation is a clinical decision based on the patient's stability and consistent heart rate control at a stable infusion rate. There is no direct, universally accepted conversion formula. A common approach involves initiating an oral diltiazem regimen (e.g., diltiazem extended-release) and subsequently weaning the IV infusion. This process requires careful monitoring and should be guided by institutional protocols and clinical judgment.

Managing Infusion Interruptions

For a continuous infusion, the concept of a "missed dose" does not apply in the traditional sense. If the infusion is stopped or interrupted, the patient's heart rate may increase. The infusion should be restarted as soon as possible, potentially at the previous effective rate. A re-bolus may be considered if there is a significant return of rapid ventricular response, as directed by the treating clinician.

Safety Alerts

Disclaimer: This information is for educational purposes and is not a substitute for professional medical advice. Consult official prescribing information and institutional guidelines before administering diltiazem.

Contraindications

IV diltiazem is contraindicated in patients with:

  • Severe hypotension or cardiogenic shock.
  • Sick sinus syndrome (unless a functioning ventricular pacemaker is in place).
  • Second- or third-degree atrioventricular (AV) block (unless a functioning ventricular pacemaker is in place).
  • Known hypersensitivity to diltiazem.

Monitoring

Continuous ECG and blood pressure monitoring are essential during IV diltiazem administration due to the risk of hypotension and bradycardia. Use with caution in patients with heart failure or impaired hepatic/renal function.

Frequently Asked Questions (FAQ)

What are the standard concentrations for diltiazem infusions?

The most common premixed concentrations are 125 mg in 100 mL (1.25 mg/mL) and 100 mg in 100 mL (1 mg/mL). The calculator also includes an option for 250 mg in 250 mL, which is also 1 mg/mL.

How does the calculator determine the bolus volume?

The calculator assumes a standard diltiazem vial concentration of 5 mg/mL for the IV push bolus. It calculates the total required dose in mg (weight x mg/kg dose) and then divides by 5 to find the volume in mL.

Why is patient weight required for the infusion calculation?

Patient weight is necessary to calculate the dose in weight-based units (mcg/kg/min). This is a standard way to express dosing that allows for comparison across patients of different sizes, even though the infusion itself is typically titrated based on the mg/hr rate.

What is the difference between the "mg/hr" and "mcg/kg/min" doses?

mg/hr is a time-based rate representing the total mass of drug delivered per hour. This is how the pump is programmed and titrated. mcg/kg/min is a weight-based rate that normalizes the dose to the patient's weight, making it easier to compare dosing intensity.

Can I use this calculator for indications other than AFib/AFlutter?

This calculator is specifically designed based on the dosing protocols for atrial fibrillation/flutter with RVR. Use for other indications should only be done under the guidance of a physician and with reference to appropriate clinical protocols.

What is the purpose of the Titration Table Generator?

The titration table provides a quick reference chart based on your selected drug concentration. It shows the corresponding infusion rate (mL/hr) for common target doses (mg/hr), saving time and reducing the need for manual calculations during titration.

What should I do if the calculator's result seems incorrect?

Always double-check your inputs for accuracy, including patient weight, units, and concentration details. Manually verify the calculation using the formulas provided in the "Formulas Used" section. This tool is for support and does not replace clinical judgment.

Is there an absolute maximum dose for a diltiazem infusion?

While the typical maximum dose is 15 mg/hr, higher rates up to 20 mg/hr have been used. Any dose exceeding 15 mg/hr requires careful clinical consideration of risks versus benefits and intensified patient monitoring.

References

  1. U.S. Food and Drug Administration (FDA). (2021). CARDIZEM (diltiazem hydrochloride) injection prescribing information. Retrieved from accessdata.fda.gov
  2. DailyMed - National Library of Medicine. (2023). Diltiazem Hydrochloride Injection Label. Retrieved from dailymed.nlm.nih.gov
  3. January CT, et al. (2019). 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation. Circulation, 140(2), e125-e151.
  4. Tisdale, J. E., & Miller, D. A. (2017). Drug-induced diseases: Prevention, detection, and management (3rd ed.). American Society of Health-System Pharmacists.
PRO
Ad-Free Access
$3.99 / month
  • No Interruptions
  • Faster Page Loads
  • Support Content Creators